Deborah L. Holliday

2.8k total citations · 1 hit paper
20 papers, 2.3k citations indexed

About

Deborah L. Holliday is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Deborah L. Holliday has authored 20 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in Deborah L. Holliday's work include Cancer Cells and Metastasis (7 papers), Cell Adhesion Molecules Research (6 papers) and Protease and Inhibitor Mechanisms (5 papers). Deborah L. Holliday is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Cell Adhesion Molecules Research (6 papers) and Protease and Inhibitor Mechanisms (5 papers). Deborah L. Holliday collaborates with scholars based in United Kingdom, Netherlands and Spain. Deborah L. Holliday's co-authors include Valerie Speirs, J. Louise Jones, Andrew M. Hanby, Jacqui Shaw, Dylan R. Edwards, Caroline J. Pennington, Rosemary A. Walker, Claude Chelala, Safia Danovi and Nicholas R. Lemoine and has published in prestigious journals such as The Lancet, PLoS ONE and Cancer Research.

In The Last Decade

Deborah L. Holliday

18 papers receiving 2.3k citations

Hit Papers

Choosing the right cell l... 2011 2026 2016 2021 2011 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah L. Holliday United Kingdom 14 1.2k 893 622 462 277 20 2.3k
Aurelio Lorico United States 30 1.7k 1.4× 1.2k 1.3× 724 1.2× 171 0.4× 190 0.7× 82 2.8k
Malathy P.V. Shekhar United States 28 1.2k 1.0× 812 0.9× 488 0.8× 198 0.4× 383 1.4× 56 2.3k
Germana Rappa United States 29 1.6k 1.3× 1.2k 1.4× 644 1.0× 158 0.3× 175 0.6× 61 2.6k
Steven D. Shnyder United Kingdom 30 1.4k 1.2× 712 0.8× 319 0.5× 176 0.4× 224 0.8× 98 2.5k
Gillian Farnie United Kingdom 25 1.9k 1.5× 1.8k 2.0× 668 1.1× 202 0.4× 166 0.6× 41 3.1k
Evgeny V. Denisov Russia 22 679 0.6× 700 0.8× 494 0.8× 236 0.5× 191 0.7× 92 1.6k
Xiongwen Zhang China 34 2.0k 1.6× 529 0.6× 385 0.6× 316 0.7× 125 0.5× 95 2.9k
Melissa D. Landis United States 23 940 0.8× 868 1.0× 393 0.6× 146 0.3× 278 1.0× 28 1.8k
Małgorzata Czyż Poland 32 2.0k 1.6× 847 0.9× 697 1.1× 334 0.7× 82 0.3× 112 3.2k
Min Xiao China 24 1.6k 1.3× 624 0.7× 601 1.0× 207 0.4× 165 0.6× 73 3.0k

Countries citing papers authored by Deborah L. Holliday

Since Specialization
Citations

This map shows the geographic impact of Deborah L. Holliday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah L. Holliday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah L. Holliday more than expected).

Fields of papers citing papers by Deborah L. Holliday

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah L. Holliday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah L. Holliday. The network helps show where Deborah L. Holliday may publish in the future.

Co-authorship network of co-authors of Deborah L. Holliday

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah L. Holliday. A scholar is included among the top collaborators of Deborah L. Holliday based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah L. Holliday. Deborah L. Holliday is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roberts, John E., Laura Monje‐Garcia, Robert J. Theobald, et al.. (2025). Putting the patient at the centre: a call for research involvement of nurses, midwives and allied health professionals working in genomics. BMJ Open. 15(8). e086962–e086962.
2.
Watson, Christopher M., Deborah L. Holliday, Laura A. Crinnion, & David T. Bonthron. (2022). Long‐read nanopore DNA sequencing can resolve complex intragenic duplication/deletion variants, providing information to enable preimplantation genetic diagnosis. Prenatal Diagnosis. 42(2). 226–232. 11 indexed citations
3.
Kamal, Mohamed, Deborah L. Holliday, Ewan E. Morrison, et al.. (2017). Loss of CSMD1 expression disrupts mammary duct formation while enhancing proliferation, migration and invasion. Oncology Reports. 38(1). 283–292. 18 indexed citations
4.
Maltby, Sarah, et al.. (2016). An Evaluation of Matrix-Containing and Humanised Matrix-Free 3-Dimensional Cell Culture Systems for Studying Breast Cancer. PLoS ONE. 11(6). e0157004–e0157004. 13 indexed citations
5.
Nash, Claire, Georgia Mavria, Euan W. Baxter, et al.. (2015). Development and characterisation of a 3D multi-cellularin vitromodel of normal human breast: a tool for cancer initiation studies. Oncotarget. 6(15). 13731–13741. 25 indexed citations
6.
Verghese, Eldo T., Ruth Drury, Caroline Green, et al.. (2014). Role of miR-26b in carcinoma-associated fibroblasts and effect on migration and invasion of breast cancer epithelial cells. The Lancet. 383. S103–S103. 1 indexed citations
7.
Verghese, Eldo T., Ruth Drury, Deborah L. Holliday, et al.. (2013). MiR‐26b is down‐regulated in carcinoma‐associated fibroblasts from ER‐positive breast cancers leading to enhanced cell migration and invasion. The Journal of Pathology. 231(3). 388–399. 99 indexed citations
8.
Hanby, Andrew M., et al.. (2012). Clinical and functional significance of loss of caveolin‐1 expression in breast cancer‐associated fibroblasts. The Journal of Pathology. 227(4). 490–498. 87 indexed citations
9.
Holliday, Deborah L., Steven Pollock, Sally Lane, et al.. (2012). The practicalities of using tissue slices as preclinical organotypic breast cancer models. Journal of Clinical Pathology. 66(3). 253–255. 49 indexed citations
10.
Holliday, Deborah L. & Valerie Speirs. (2011). Choosing the right cell line for breast cancer research. Breast Cancer Research. 13(4). 215–215. 1214 indexed citations breakdown →
11.
Cummings, Michele, Deborah L. Holliday, Kieran Horgan, et al.. (2010). Phosphorylation of Estrogen Receptor β at Serine 105 Is Associated with Good Prognosis in Breast Cancer. American Journal Of Pathology. 177(3). 1079–1086. 36 indexed citations
12.
Allen, Michael D., Michael R. Green, Claude Chelala, et al.. (2010). Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell‐surface marker of the basal phenotype that promotes tumour cell invasion. The Journal of Pathology. 223(5). 646–658. 31 indexed citations
13.
Holliday, Deborah L.. (2010). A Three-dimensional In Vitro Model of Breast Cancer: Toward Replacing the Need for Animal Experiments. Alternatives to Laboratory Animals. 38(1_suppl). 41–44. 3 indexed citations
14.
Allen, Michael D., Deborah L. Holliday, Dylan R. Edwards, et al.. (2009). Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms. Breast Cancer Research. 11(2). R24–R24. 103 indexed citations
16.
Gutiérrez‐Fernández, Ana, Antonio Fueyo, Alicia R. Folgueras, et al.. (2008). Matrix Metalloproteinase-8 Functions as a Metastasis Suppressor through Modulation of Tumor Cell Adhesion and Invasion. Cancer Research. 68(8). 2755–2763. 154 indexed citations
17.
Yuan, Ming, Romain Lara, Deborah L. Holliday, et al.. (2008). Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death and Differentiation. 15(11). 1752–1759. 271 indexed citations
18.
Pennington, C., Simon Pilgrim, Ana Gutiérrez‐Fernández, et al.. (2008). Matrix metalloproteinase-8 is a regulator of the clinical aggressiveness of mammary tumours. Breast Cancer Research. 10(S2).
19.
Holliday, Deborah L., Simon Hughes, Jacqui Shaw, Rosemary A. Walker, & J. Louise Jones. (2007). Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion. Breast Cancer Research. 9(5). R67–R67. 40 indexed citations
20.
Hughes, Simon, Olorunsola F. Agbaje, Rebecca Bowen, et al.. (2007). Matrix Metalloproteinase Single-Nucleotide Polymorphisms and Haplotypes Predict Breast Cancer Progression. Clinical Cancer Research. 13(22). 6673–6680. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026